Ann Dermatol.  2017 Oct;29(5):618-620. 10.5021/ad.2017.29.5.618.

Epstein-Barr Virus-Associated Vesiculopapular Eruption on the Face of a Patient with Natural Killer T Cell Lymphoma

• Lim JS
• Kim TM
• Cho KH

• KMID: 2388915
• DOI: http://doi.org/10.5021/ad.2017.29.5.618

Abstract

Unlike typical hydroa vacciniforme (HV), Epstein-Barr virus (EBV)-associated HV-like eruption is more variable in its clinical manifestations. In some patients, progression to lymphoma or leukemia has been reported, which are characterized by the T-cell immunophenotype. Here, we report the first Korean case of EBV-associated vesiculopapular eruption on the face of a patient with natural killer (NK)/T cell lymphoma. A 32-year-old Korean man presented with a late adolescent-onset recurrent necrotic papulovesicles on his face. The patient was previously diagnosed with EBV-associated NK/T cell lymphoma of the oral cavity and also had childhood-onset hypersensitivity to mosquito bites. Biopsy of his facial skin showed EBV-associated vesiculopapular eruptions, though ultraviolet provocation did not reproduce the skin lesions. EBV viral load in his peripheral blood was detected but low. The patient was treated with systemic chemotherapy. The lymphoma went into remission, but the facial EBV-associated vesiculopapular eruption had a relapsing and remitting course.

Keyword

Epstein-Barr virus; Epstein-Barr virus-associated hydroa vacciniforme-like eruption; Epstein-Barr virus-associated vesiculopapular eruption; hydroa vacciniforme; natural killer T cell lymphoma

MeSH Terms

Adult
Biopsy
Culicidae
Drug Therapy
Herpesvirus 4, Human
Humans
Hydroa Vacciniforme
Hypersensitivity
Leukemia
Lymphoma*
Mouth
Natural Killer T-Cells*
Skin
T-Lymphocytes
Viral Load

Figure

• 

  Fig. 1 (A) Mild erythematous and edematous papulovesicular eruptions on the patient's face. (B) Microscopic findings of small to medium sized lymphocytic infiltration through dermis (H&E, ×100). (C) In situ hybridization. Epstein-Barr virus early RNA (EBER) positive lymphocytes are found in biopsy specimen (EBER, ×100).

Reference

1. Cho KH. Epstein-Barr virus associated hydroa vacciniforme-like eruption. Korean J Dermatol. 2011; 49:773–779.

2. Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol. 2002; 147:587–591.

3. Cho KH, Kim CW, Lee DY, Sohn SJ, Kim DW, Chung JH. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face. Br J Dermatol. 1996; 134:791–796.

4. Cho KH, Kim CW, Heo DS, Lee DS, Choi WW, Rim JH, et al. Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions. Clin Exp Dermatol. 2001; 26:242–247.

5. Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol. 2001; 45:569–578.

6. Huh SY, Choi M, Cho KH. A case of Epstein-Barr virus-associated hydroa vacciniforme. Ann Dermatol. 2009; 21:209–212.

7. Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol. 2006; 142:587–595.

8. Cho KH, Li KS, Kim YK, Jeon YK, Kim CW, Lee SK, et al. Epstein-Barr virus associated lymphoproliferative lesion presenting as a hydroa vacciniforme-like eruption. Korean J Dermatol. 2004; 42:846–855.

9. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127:2375–2390.

10. Zhang G, Bai HX, Yang L, Ma MH, Su Y, Luo Y, et al. NK-/T-cell lymphoma resembling hydroa vacciniforme with positive CD4 marker expression: a diagnostic difficulty. Am J Dermatopathol. 2013; 35:94–97.

11. Maeda A, Wakiguchi H, Yokoyama W, Hisakawa H, Tomoda T, Kurashige T. Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection. J Infect Dis. 1999; 179:1012–1015.